May 31 (Reuters) - Synlab SYAB.DE has signed a
delisting agreement with Ephios Bidco, the German medical
diagnostics provider said in a statement on Friday.
Ephios, a holding company controlled by investment funds
advised by Cinven Limited, said it would make a public delisting
acquisition offer to Synlab's shareholders to acquire the rest
of the shares it does not hold.
The holding company already has around 86% of voting rights
in the medical diagnostics provider, Synlab said in a statement.
Shares in Synlab are up 4.72% at 0718 GMT
(Reporting by Paolo Laudani, Editing by Rachel More)
((Paolo.Laudani@thomsonreuters.com;))